Carelon Research
Carelon Research is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
(21467) A Phase 3, single-arm, open-label extension study to evaluate the safety of finerenone in addition to standard of care, in pediatric heart failure patients, from birth to 18 years of age, with left ventricular systolic dysfunction (LVSD)
Sponsor Bayer AG
- Start (EU)
- Latest update
- Estimated end
A multicenter, randomized, double-blind, placebo-controlled, Phase 3 study to investigate the efficacy, safety, and PK/ PD of finerenone, in addition to standard-of-care, in pediatric patients, 6 months to < 18 years of age with heart failure (HF) and left ventricular systolic dysfunction (LVSD)
Sponsor Bayer AG
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Carelon Research?
The 2026-10-09 snapshot links Carelon Research to 2 distinct CTIS trials. Recorded services include scientific advice, Scientific advice. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Carelon Research?
The most frequently recorded therapeutic areas are Cardiology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Carelon Research conducted?
The linked trials record locations in 13 countries, including Austria, Belgium, Bulgaria, Czechia, Germany. These are trial locations, not confirmed office locations or countries where Carelon Research delivered services.
What can this page tell me about Carelon Research's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Carelon Research. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Carelon Research Inc